The post-approval safety profile of cladribine tablets in relapsing MS was updated, with results consistent with development ...

A coroner has described coming across a "first" in his lengthy career during an inquest examining safety of elderly drivers.

Reports revenue RMB 980.7M vs. RMB 221.9M last year. Dajun Yang, CEO, said, “As we reflect on our achievements in 2024, I am delighted to ...

Olverembatinib (HQP1351), a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI, has been approved in ...